Related Experiment Video
Updated: Feb 1, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
To revascularize or not before transcatheter aortic valve implantation?
Sergio Perez1, Torin P Thielhelm2, Mauricio G Cohen1
1Cardiovascular Division, University of Miami Miller School of Medicine, Miami, FL, USA.
Insights
Management of coronary artery disease (CAD) in patients undergoing transcatheter aortic valve replacement (TAVR) is complex. While guidelines exist for surgical repair, TAVR introduces new considerations for revascularization strategies to optimize patient outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Concomitant coronary artery disease (CAD) and aortic stenosis affect 60-75% of patients undergoing aortic valve replacement.
- Current guidelines recommend simultaneous surgical aortic valve replacement and bypass surgery for CAD, based on limited evidence.
- Transcatheter aortic valve replacement (TAVR) has challenged traditional revascularization strategies, with observational studies showing no significant outcome differences in TAVR patients with or without CAD.
Purpose of the Study:
- To review the management of coronary artery disease (CAD) in patients undergoing transcatheter aortic valve replacement (TAVR).
- To discuss the indications, timing, and technical considerations for percutaneous coronary intervention (PCI) in TAVR candidates.
- To explore adjunctive pharmacological therapies and future research directions.
Main Methods:
- Review of current guidelines and observational studies.
- Analysis of percutaneous coronary intervention (PCI) strategies before, during, and after TAVR.
- Discussion of technical aspects, device selection, and pharmacological therapies.
Main Results:
- Percutaneous coronary intervention (PCI) in aortic stenosis patients is safe, but optimal timing and indications remain debated.
- Complete revascularization before TAVR may benefit selected patients with extensive CAD.
- Combined PCI and TAVR or PCI after TAVR are options for specific clinical scenarios.
Conclusions:
- The optimal management of CAD in TAVR candidates requires careful consideration of individual patient factors and lesion characteristics.
- Randomized clinical trials are needed to further clarify the role and indications of revascularization in the TAVR population.
- This review provides comprehensive insights into managing CAD in TAVR candidates, including technical and pharmacological aspects.
Abstract:
Concomitant coronary artery disease (CAD) and aortic stenosis occur in approximately 60-75% of patients referred for surgical or transcatheter aortic valve replacement (TAVR). Current guidelines support simultaneous surgical aortic valve replacement and bypass surgery with a class IIa recommendation, based on observational, non-randomized data. With the inception of TAVR, this strategy has been challenged, as observational studies have not shown significant outcome differences in patients with and without CAD treated with TAVR. Performing percutaneous coronary intervention (PCI) in patients with aortic stenosis is safe, but the indication and timing remain controversial. Complete revascularization before TAVR with low residual Syntax score (<8) may be considered in selected cases with extensive, proximal, and severe CAD to improve outcomes. PCI before TAVR may require less contrast and reduce the risk of acute kidney injury, but uninterrupted dual antiplatelet therapy may increase the risk of bleeding during TAVR. Combined PCI and TAVR can be considered for unstable patients with simple lesions or ostial lesions, with risk of coronary occlusion after deployment of the transcatheter heart valve. PCI after TAVR may be considered in patients who remain symptomatic with significant residual ischemia despite optimal medical therapy. In the near future, it is expected that randomized clinical trials will further clarify the indications and role of revascularization in patients undergoing TAVR. In this article we provide an extensive review on the management of CAD in TAVR candidates, including additional considerations on technical aspects, device selection, and adjunctive pharmacological therapies.
More Related Videos
06:59Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
06:04Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Related Concept Videos
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Valve Prolapse I: Introduction
Aortic Regurgitation I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse III: Nursing Management
Aortic Regurgitation III: Medical Management